We offer a wide range of research products and services for public and privately held life science companies, corporate investors, venture capitalists, and institutional investors.
COMPANIES
Public companies
Full research coverage, including
-
Valuation Report (comprehensive company analysis, forecasts and valuation)
-
Research distribution through various channels (e.g. company website, Bloomberg Terminal, Thomson Reuters platform, LinkedIn, targeted email
lists, newswires)
-
Investor Call to main shareholders
Private companies
On a project base, we provide special reports that can be used for business development, M&A activities or to attract new capital, including
-
Valuation Report (comprehensive company and/or product analyses and valuation)
-
Fairness opinion
-
Investor access to find the right strategic partners or investors through our extensive network
INVESTORS
For corporate investors, venture capitalists, and institutional investors, we provide independent assessments and valuations on potential investments,
including
-
Company Valuation
-
Product Valuation
-
Second Opinion
Interested in coverage of your company by valuationLAB? This can be achieved
typically within 4-6 weeks at a competitive price.